Rofecoxib potentiates the anticonvulsant effect of topiramate

Inflammopharmacology

Volumn 16, Issue 2, 2008, Pages 83-86

  Dhir, A ^a   Akula, K K ^a   Kulkarni, S K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Brain; COX 2 inhibitors; Cyclooxygenase; Epilepsy; Rofecoxib; Topiramate

Indexed keywords

PENTETRAZOLE; ROFECOXIB; TOPIRAMATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CLONUS; CONTROLLED STUDY; CONVULSION; DRUG POTENTIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FRUCTOSE; LACTONES; MALE; MICE; PENTYLENETETRAZOLE; SEIZURES; SULFONES;

EID: 42049116112     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-007-7007-6     Document Type: Article

References (29)

1. Ahuja, N., Singh, A., Singh, B. (2003). Rofecoxib, an update on physicochemical, pharmaceutical, pharmacodynamic and pharmacokinetic aspects, J. Pharm. Pharmacol. 55, 859-94.
2. Akula, K. K., Dhir, A., Bishnoi, M., Kulkarni, S. K. (2007). Effect of systemic administration of adenosine on brain adenosine levels in pentylenetetrazol-induced seizure threshold in mice, Neurosci Lett. 425, 39-42.
3. Angehagen, M., Ben-Menachem, E., Rönnbäck, L., Hansson, E. (2003). Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and topiramate, Neurochem Res. 28, 333-40.
4. Bazan, N. G. (2003). Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activationg factor, J. Lipid Res. 44, 2221-33.
5. Borowicz, K. K., Luszczki, J. J., Duda, A. M., Czuczwar, S. J. (2003). Effect of topiramate on the anticonvulsant activity of conventional antiepileptic drugs in two models of experimental epilepsy, Epilepsia 44, 640-6.
6. Clark, G. D., Happel, L. T., Zorumski, C. F., Bazan, N. Z. (1994). The role of platelet activating factor in the release of excitotoxic neurotransmitters, J Lipid Mediators and cell signaling 10, 95-7.
7. Dhir, A., Kulkarni, S. K. (2006). Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor potentiates the anticonvulsant activity of tiagabine against pentylenetetrazol-induced convulsions in mice, Inflammopharmacology 14, 222-5.
8. Dhir, A., Naidu, P. S., Kulkarni, S. K. (2005). Protective effect of naproxen, a non-selective COX-inhibitor on PTZ-induced kindling in mice, Clinical and Experimental Pharmacology and Physiology 32, 574-84.
9. Dhir, A., Naidu, P. S., Kulkarni, S. K. (2006a). Effect of cyclooxygenase inhibitors on pentylenetetrazol (PTZ)-induced convulsions, possible mechanism of action, Progress in Neuropsychopharmacology and Biological Psychiatry 30, 1478-85.
10. Dhir, A., Naidu, P. S., Kulkarni, S. K. (2006b). Effect of cyclooxygenase inhibitors on various animal models (picrotoxin, bicuculine and maximal electroshock-induced convulsions, possible GABAergic mechanism of action, Indian Journal of Experimental Biology 44, 286-91.
11. Dhir, A., Naidu, P. S., Kulkarni, S. K. (2006c). Effect of rofecoxib, a cyclooxygenase-2 (COX-2) inhibitor, on various biochemical parameters of brain associated with pentylenetetrazol (PTZ)-induced chemical kindling in mice, Fundamental and Clinical Pharmacology 20, 255-61.
12. Jain, N. K., Kulkarni, S. K., Singh, A. (2001). Lipopolysaccharide- mediated immobility in mice, reversal by cyclooxygenase enzyme inhibitor, Method Find. Exp. Clin. Pharmacol. 23, 441-4.
13. Kaminski, R., Kozicka, M., Parada-Turska, J., et al. (1998). Effect of non-steroidal anti-inflammatory drugs on the anticonvulsive profile of valproate and diphenylhydantoin against maximal electroshock-induced seizures in mice, Pharmacol. Res. 37, 375-81.
14. Kukreja, R. C., Kontos, H. A., Hess, M. L., Ellis, E. F. (1993). PGH synthase and Lipoxygenase generate Superoxide in the presence of NADH or NADPH, Circ. Res. 30, 305-12.
15. Kulkarni, S. K. (2005). Experiments on intact preparations. In: Kulkarni SK, editors. Handbook of Experimental Pharmacology. Delhi: Vallabh Prakashan, p. 133-4.
16. Kunz, T., Oliw, E. H. (2001). The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus, Eur J Neurosci. 13, 569-75.
17. Lyseng-Williamson, K. A., Yang, L. P. (2007). Topiramate: a review of its use in the treatment of epilepsy, Drugs 67, 2231-56.
18. Maida, M. E., O'Banion, M. K. (2001). The cyclooxygenase in neuroinfl ammation and neurodegeneration: Emerging perspectives, Inflammatory Events In Neurodegeneration, 158-189.
19. Mccown, T. J., Knapp, D. J., Crews, F. T. (1997) Inferior collicular seizure generalization produces site-selective cortical induction of cyclooxygenase-2 (COX-2), Brain Res. 767, 370-4.
20. Minghetti, L. (2004). Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases, J. Neuropathol. Exp. Neurol. 63, 901-10.
21. Nielsen, E. B., Suzdak, P. D., Andersen, K. E., et al. (1991). Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor, Eur. J. Pharmacol. 196, 257-72.
22. Okada, K., Yuhi, T., Tsuji, S., Yamashita, U. (2001). Cyclooxygenase-2 expression in the hippocampus of genetically epilepsy susceptible El mice was increased after seizure, Brain Research 894, 332-5.
23. Park, H. J., Kim, H. J., Park, H. J., Ra, J., Zheng, L. T., Yim, S. V., et al. (2008). Protective effect of topiramate on kainic acid-induced cell death in mice hippocampus, Epilepsia 49, 163-7.
24. Shafiq, N., Malhotra, S., Pandhi, P. (2003). Anticonvulsant action of celecoxib (alone and in combination with sub-threshold dose of phenytoin) in electroshock induced convulsions, Methods Find. Exp. Clin. Pharmacol. 25, 87-90.
25. Takemiya, T., Suzuki, K., Sugiura, H., et al. (2003). Inducible brain COX-2 facilitates the recurrence of hippocampal seizures in mouse rapid kindling, Prostaglandins & Other Lipid Medi. 71, 205-16.
26. Tandon, M., Anuradha, K., Pandhi, P. (2003). Evaluation of antiepileptic activity of aspirin in combination with newer antiepileptic lamotrigine in mice, Method Find. Exp. Clin. Pharmacol. 25, 607-10.
27. Wauquier, A., Zhou, S. (1996). Topiramate: a potent anticonvulsant in the amygdala-kindled rat, Epilepsy Res. 24, 73-7.
28. White, H. S., Brown, S. D., Woodhead, J. H., et al. (1997). Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold, Epilepsy Res. 28, 167-79.
29. White, H. S., Brown, S. D., Woodhead, J. H., et al. (2000). Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism, Epilepsia 41, S17-S0.